Research ArticleNuclear Oncology
Iodine-123-Vasoactive Intestinal Peptide Receptor Scanning in Patients with Pancreatic Cancer
Markus Raderer, Amir Kurtaran, Qiong Yang, Susan Meghdadi, Friedrich Vorbeck, Michael Hejna, Peter Angelberger, Gabriela Kornek, Johann Pidlich, Werner Scheithauer and Irene Virgolini
Journal of Nuclear Medicine September 1998, 39 (9) 1570-1575;
Markus Raderer
Amir Kurtaran
Qiong Yang
Susan Meghdadi
Friedrich Vorbeck
Michael Hejna
Peter Angelberger
Gabriela Kornek
Johann Pidlich
Werner Scheithauer
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Iodine-123-Vasoactive Intestinal Peptide Receptor Scanning in Patients with Pancreatic Cancer
Markus Raderer, Amir Kurtaran, Qiong Yang, Susan Meghdadi, Friedrich Vorbeck, Michael Hejna, Peter Angelberger, Gabriela Kornek, Johann Pidlich, Werner Scheithauer, Irene Virgolini
Journal of Nuclear Medicine Sep 1998, 39 (9) 1570-1575;
Iodine-123-Vasoactive Intestinal Peptide Receptor Scanning in Patients with Pancreatic Cancer
Markus Raderer, Amir Kurtaran, Qiong Yang, Susan Meghdadi, Friedrich Vorbeck, Michael Hejna, Peter Angelberger, Gabriela Kornek, Johann Pidlich, Werner Scheithauer, Irene Virgolini
Journal of Nuclear Medicine Sep 1998, 39 (9) 1570-1575;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
- Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
- In Vivo Imaging of Human Colon Cancer Xenografts in Immunodeficient Mice Using a Guanylyl Cyclase C-Specific Ligand
- Effects of Chemotherapeutic Agents on Expression of Somatostatin Receptors in Pancreatic Tumor Cells
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
- Value of Peptide Receptor Scintigraphy Using 123I-Vasoactive Intestinal Peptide and 111In-DTPA-D-Phe1-Octreotide in 194 Carcinoid Patients: Vienna University Experience, 1993 to 1998